Neuro-oncologic emergencies are commonly encountered in critical care. Rapidly evolving biological therapies for cancer offer patients exciting benefits, but have also created new sets of complications (e.g., checkpoint inhibitor-induced encephalitis). Patients may be suffering from complications of the malignancy itself, complications of therapy, or wholly unrelated problems.
The IBCC chapter is located 👉 here.
- The podcast & comments are below.